Substance use disorders are complex conditions in which an individual has an uncontrolled use of a substance despite harmful consequences.
Alcohol use disorder (AUD) is a medical condition characterised by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences1.
Approximately 280 million people suffer with alcohol use disorder (AUD) worldwide2 with around 3 million deaths each year attributed to the harmful use of alcohol3.
Less than 20% of individuals with AUD get any treatment4 and there is a 40-60% lifetime relapse rate associated with the condition5.
These conditions carry a significant burden not only on the people living with the condition but also their family, community, healthcare system and society more broadly. There is an urgent demand for better, faster-acting and more effective medical treatments.
About our Substance Use Disorders clinical development programme
We are investigating BPL-003 - our novel synthetic intranasal formulation of 5-MeO-DMT benzoate - as a potential treatment for Alcohol Use Disorder.
Links to other websites do not imply affiliation or endorsement. Beckley Psytech does not control and is not responsible for their content.
